国产v在线在线观看视频免费,一,日本韩国欧美一区二区三区,亚洲和欧洲一码二码区别在哪里呢

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
5 mg	3-5days	￥600.00	登錄后可見(jiàn)	- +
10 mg	3-5days	￥900.00	登錄后可見(jiàn)	- +
25 mg	3-5days	￥1600.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

5 mg

3-5days

￥600.00

登錄后可見(jiàn)

- +

10 mg

3-5days

￥900.00

登錄后可見(jiàn)

- +

25 mg

3-5days

￥1600.00

登錄后可見(jiàn)

- +

基本信息

英文名稱	Sotuletinib (BLZ945)
中文名稱	Sotuletinib (BLZ945)
CAS號(hào)	953769-46-5
分子式	C20H22N4O3S
分子量	398.48
外觀	Off-white to light brown powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Sotuletinib (formerly BLZ945; BLZ-945) is a novel, potent, selective, orally bioactive, and brain-penetrant CSF-1R (colony stimulating factor 1 receptor) inhibitor with potential antitumor activity. It exhibits 1000-fold higher selectivity against its closest receptor tyrosine kinase homologs and inhibits CSF-1R with an IC50 of 1 nM. Glioma-bearing mice demonstrate high in vivo antitumor efficaciousness of BLZ945. Sotuletinib was designated as an orphan drug by the US FDA in August 2022 in order to treat patients suffering from Amyotrophic Lateral Sclerosis (ALS), a progressive neurological disorder that affects nerve cells in the brain and spinal cord and results in loss of motor control.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL2550

Sotuletinib (BLZ945)

953769-46-5 98+% 3-5days

￥600.00 5 mg

黄片一区二区三区在线观看-亚洲av综合久久国产激情按摩店-欧美日韩国产长车超污-欧美日韩偷拍精品视频

Sotuletinib (BLZ945)

Sotuletinib (BLZ945)

化學(xué)品安全說(shuō)明書(shū)(MSDS)